Canopy Growth - CEO, David Klein.
CEO, David Klein.
Source: Nasdaq and Vanja Savic.
  • Canopy Growth (TSX:WEED) is announcing a private placement with institutional investors for up to US$50 million
  • Management intends to use the funds for working capital and general corporate purposes
  • Canopy Growth is a North American cannabis and consumer packaged goods company
  • Canopy Growth stock (TSX:WEED) is up by 258.82 per cent since its 52-week low on July 14, 2023

Canopy Growth (TSX:WEED) is announcing a private placement with institutional investors for up to US$50 million.

Management intends to use the funds to strengthen its balance sheet through working capital and general corporate purposes.

The agreement entails the sale of up to 22,929,468 units priced at US$1.09 for proceeds of US$25 million.

Each unit is composed of one WEED common share and one common share purchase warrant. Each warrant entitles the holder to acquire one common share for US$1.35 for up to five years from issuance.

The institutional investors hold an over-allotment option to acquire up to an additional 22,929,468 units at the US$1.09 price.

Closing of the agreement (not including the over-allotment option) is expected by Tuesday.

The news follows a stretch of positive momentum for Canopy Growth’s stock, as highlighted by:

Canopy Growth is a North American cannabis and consumer packaged goods company. Its brands include Doja, 7ACRES, Tweed, Deep Space, This Works, Martha Stewart CBD and Storz & Bickel.

The company is positioned to capitalize on U.S. cannabis legalization through its rights to Acreage Holdings, a vertically integrated multi-state cannabis operator across the Northeast; Wana Brands, a leading cannabis edible brand in North America; and Jetty Extracts, a California-based producer of cannabis extracts and pioneer of clean vape technology.

Canopy Growth stock (TSX:WEED) last traded at $1.83 per share. The stock is up by 258.82 per cent since its 52-week low on July 14, 2023.

Join the discussion: Find out what everybody’s saying about this Canadian cannabis stock on the Canopy Growth Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.